Primary intracerebral Hodgkin's disease: report of a case with Epstein-Barr virus association and review of the literature

Am J Surg Pathol. 1999 Apr;23(4):477-81. doi: 10.1097/00000478-199904000-00014.

Abstract

A case of primary intracerebral Hodgkin's disease (HD) without dural attachment in a 54-year-old immunocompetent patient is described. The infiltrate was located superficially in the occipital lobe and corresponded to the histologic type of nodular sclerosis. A typical immunohistochemical profile (membrane and cytoplasmic staining with dotlike Golgi enhancement of CD30, moderate cytoplasmic staining of CD15 in the Golgi area, membrane staining of CD20 of <10% of blastic cells, CD45RB negative) and in addition Epstein-Barr virus (EBV) latent membrane protein was detectable in Reed-Sternberg cells. Staging revealed no other organ sites of involvement. After combined surgery, postoperative radiotherapy, and chemotherapy, there are no signs of recurrence or systemic disease on follow-up for >1 year. To the authors' best knowledge, an association of EBV with primary central nervous system HD has not been demonstrated before.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers, Tumor / analysis
  • Brain / pathology
  • Brain Neoplasms / pathology*
  • Brain Neoplasms / therapy
  • Brain Neoplasms / virology
  • Combined Modality Therapy
  • Cyclophosphamide / therapeutic use
  • Herpesviridae Infections / pathology*
  • Herpesviridae Infections / virology
  • Herpesvirus 4, Human / isolation & purification
  • Herpesvirus 4, Human / pathogenicity*
  • Hodgkin Disease / pathology*
  • Hodgkin Disease / therapy
  • Hodgkin Disease / virology
  • Humans
  • Immunoenzyme Techniques
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Prednisone / therapeutic use
  • Procarbazine / therapeutic use
  • Treatment Outcome
  • Tumor Virus Infections / pathology*
  • Tumor Virus Infections / virology
  • Vincristine / therapeutic use

Substances

  • Biomarkers, Tumor
  • Procarbazine
  • Vincristine
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • COPP protocol